Lb Pharmaceuticals (LBRX) Change in Acquisitions & Divestments (2024 - 2025)
Lb Pharmaceuticals (LBRX) recorded quarterly Change in Acquisitions & Divestments of $1000.0 in Q4 2025, down 99.96% quarter-over-quarter from $2.5 million in Q1 2025, and down 99.99% on a YoY basis from $7.3 million in Q4 2024.
Lb Pharmaceuticals (LBRX) Change in Acquisitions & Divestments (2024 - 2025) Analysis & Trends
Lb Pharmaceuticals' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $1000.0 for Q4 2025.
- In Q4 2025, Change in Acquisitions & Divestments fell 99.99% year-over-year to $1000.0; the TTM figure through Mar 2026 stood at $9.8 million (changed N/A YoY), while the FY2025 annual figure was $2.5 million, down 91.69% from the prior year.
- Change in Acquisitions & Divestments was $1000.0 for Q4 2025 at Lb Pharmaceuticals, down from $2.5 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $7.3 million in Q4 2024 to a low of $1000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lb Pharmaceuticals | 843.30 Mn | 843.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Mar 31, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 7.27 Mn |
| Dec 31, 2024 | 7.27 Mn |